ExThera Medical’ Seraph Microbind Affinity Blood Filter Demonstrates Potential for Reducing High Death Rate From Sepsis, a Top-10 Cause of Death in the U.S.

September 10, 2012 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BERKELEY, Calif.--(BUSINESS WIRE)-- ExThera Medical announced today that its Seraph™ (Selective Removal by Apheresis) Microbind™ Affinity Blood Filter continues to receive enthusiastic scientific scrutiny for its potential to thwart sepsis-induced systemic inflammation and organ dysfunction.

Twitter
LinkedIn
Facebook
Email
Print

ExThera Medical’ Seraph Microbind Affinity Blood Filter Demonstrates Potential for Reducing High Death Rate From Sepsis, a Top-10 Cause of Death in the U.S.

ExThera Medical’ Seraph Microbind Affinity Blood Filter Demonstrates Potential for Reducing High Death Rate From Sepsis, a Top-10 Cause of Death in the U.S.